文献速递脑血管病认知障碍与痴呆

皮质卒中后丘脑退变中出现独特的小胶质细胞亚型

Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke.
PubMed 文献 · Stroke · 2021-01-08

该研究在小鼠左侧大脑中动脉永久闭塞模型上,用靶向转录组、组织学和流式细胞术观察皮质卒死后同侧丘脑的继发性退变和小胶质细胞反应。丘脑退变在PD7可检出并于PD28加重,小胶质细胞PD1即激活且早于退变;PD28转录组显示神经炎症通路最激活、小胶质细胞最富集,Itgax(CD11c)基因升高最显著。流式分选的CD11c+小胶质细胞呈现神经退行性疾病相关小胶质细胞特征。

要点

  • 皮质卒中后同侧丘脑出现进行性退变,PD7可检出、PD28加重。
  • 小胶质细胞PD1即激活,早于丘脑退变,PD28神经炎症通路最激活。
  • 退变丘脑存在CD11c+小胶质细胞亚型,具疾病相关小胶质细胞分子特征。

核心结论

  • 皮质卒中后同侧丘脑发生进行性退变,并出现具有神经退行性疾病相关特征的小胶质细胞CD11c+亚型。

研究设计与样本

  • 雄性C57BL6J小鼠永久闭塞左侧大脑中动脉建立皮质缺血性卒中模型,在卒中后第1至84天检查同侧感觉皮层和同侧丘脑。
  • 使用NanoString神经病理panel(780个基因)检测PD7和PD28转录组,并用流式细胞分选同侧丘脑CD11c+小胶质细胞、qRT-PCR验证基因表达。

主要发现

  • 丘脑退变在PD7可检出,至PD28进行性加重。
  • 小胶质细胞激活最早在PD1检出,早于神经退行性改变。
  • PD28同侧丘脑差异表达基因数量更多,神经炎症为最激活通路,小胶质细胞为最富集细胞类型。
  • Itgax(CD11c)为升高最显著的基因,其表达在小胶质细胞中高度检出。
  • 分选的CD11c+小胶质细胞Tmem119和CX3CR1下调,ApoE、Axl、LpL、CSF1和Cst7上调。

临床怎么用

  • 卒中后应关注远隔丘脑的继发性退变和小胶质细胞炎症反应,而不仅限于梗死局部。
  • CD11c+小胶质细胞可作为卒中后丘脑退变相关炎症的潜在研究靶点。

局限性

  • 研究为小鼠模型,结论向人类卒中的转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Stroke disrupts neuronal functions in both local and remotely connected regions, leading to network-wide deficits that can hinder recovery. The thalamus is particularly affected, with progressive development of neurodegeneration accompanied by inflammatory responses. However, the complexity of the involved inflammatory responses is poorly understood. Herein we investigated the spatiotemporal changes in the secondary degenerative thalamus after cortical stroke, using targeted transcriptome approach in conjunction with histology and flow cytometry. METHODS: Cortical ischemic stroke was generated by permanent occlusion of the left middle cerebral artery in male C57BL6J mice. Neurodegeneration, neuroinflammatory responses, and microglial activation were examined in naive and stroke mice at from poststroke days (PD) 1 to 84, in both ipsilesional somatosensory cortex and ipsilesional thalamus. NanoString neuropathology panel (780 genes) was used to examine transcriptome changes at PD7 and PD28. Fluorescence activated cell sorting was used to collect CD11c+ microglia from ipsilesional thalamus, and gene expressions were validated by quantitative real-time polymerase chain reaction. RESULTS: Neurodegeneration in the thalamus was detected at PD7 and progressively worsened by PD28. This was accompanied by rapid microglial activation detected as early as PD1, which preceded the neurodegenerative changes. Transcriptome analysis showed higher number of differentially expressed genes in ipsilesional thalamus at PD28. Notably, neuroinflammation was the top activated pathway, and microglia was the most enriched cell type. Itgax (CD11c) was the most significantly increased gene, and its expression was highly detected in microglia. Flow-sorted CD11c+ microglia from degenerative thalamus indicated molecular signatures similar to neurodegenerative disease-associated microglia; these included downregulated Tmem119 and CX3CR1 and upregulated ApoE, Axl, LpL, CSF1, and Cst7. CONCLUSIONS: Our findings demonstrate the dynamic changes of microglia after stroke and highlight the importance of investigating stroke network-wide deficits. Importantly, we report the existence of a unique subtype of microglia (CD11c+) with neurodegenerative disease-associated microglia features in the degenerative thalamus after stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Cao Z, Harvey SS, Chiang T, et al. Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke. Stroke. 2021. PMID: 33412903. doi:10.1161/STROKEAHA.120.032402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。